The newest addition to the BGI pharma solutions offers pharmaceutical companies a customized solution that has played a key role in the global clinical trials and development of the first innovative anti-ovarian cancer precision medicine. Cambridge, MA – BGI Americas today announced the launch of OseqTMHereditary Cancer Panel (HCP) to support global clinical trials of [...]

We’re re-writing the book on handheld pipetting with the introduction of our revolutionary MagneTips system. Complementing our popular GripTips system, the ground-breaking MagneTips technology completely eliminates the need to pick up pipette tips. Now you can simply wave the pipette over the tip box, push the button and tips will snap on automatically! The unique MagneTips system [...]

Cambridge, United Kingdom – Congenica, the global diagnostic decision support platform provider, has announced that it now offers an on-premise deployment method in addition to cloud deployment for running its SapientiaTM platform. This considerable technical achievement has been completed following feedback from customers from Government institutions, hospitals and private research organisations that they want locally operated decision [...]

Proprietary enzymatic synthesis technology produces high quality sequences up to 3000 nucleotides long PISCATAWAY, N.J. and ATLANTA -- GenScript®, the world's leading gene synthesis provider, today at the American Association for Cancer Research launched a single-stranded DNA (ssDNA) service. The new service offers researchers access to high quality, pure ssDNA for CRISPR-based gene insertion, ultimately helping to accelerate the [...]

SAN DIEGO--(BUSINESS WIRE)--Mar. 29, 2019-- Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group's subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI's sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers [...]

– Applied DNA to Receive Staged Payments Totaling $5M Over the Next Four-Months – – Agreement Calls for Annual Payment Minima that Scale from $7 Million in Year 3 to $20 Million in Year 15 – – Applied DNA Technology to Power ETCH BioTrace System to Verify Legal Cannabis and Hemp Markets Globally – STONY [...]

Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics development SOUTH SAN FRANCISCO, Calif. (March 28, 2019) Mission Bio, the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that [...]

Bengaluru, India; San Jose, USA Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd, announced today that it has added advanced Pioneer FE system to its platform of drug discovery solutions available to customers.  The Pioneer FE system from ForteBio, the Biologics Business Unit of Molecular Devices, represents the next generation SPR instrumentation for label-free [...]

PISCATAWAY, N.J. -- GenScript®, the world's leading gene synthesis provider, announced today that it will provide funding and DNA synthesis expertise toward a project at Harvard University to generate the first comprehensive, renewable library of Drosophila recombinant antibodies. Proposed by Norbert Perrimon, PhD, the James Stillman Professor of Developmental Biology at Harvard Medical Schooland a Howard Hughes Medical Institute Investigator, the [...]

Amol brings global pharmaceutical and diagnostic industry experience to management team to support rapid company growth LEXINGTON, Mass.---- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has named Amol Chaubal to the position of Chief Financial Officer (CFO), effective April 12, 2019. Amol replaces Joseph Driscoll, [...]